Cargando…
Implantable cardioverter defibrillator in nonischemic cardiomyopathy: A systematic review and meta‐analysis
The evidence to support implantable cardioverter defibrillator (ICD) in subjects with nonischemic cardiomyopathy (NICM) for primary prevention of sudden cardiac death (SCD) is not robust. This meta‐analysis intends to assess the impact of routine ICD implantation for primary prevention of mortality...
Autores principales: | Khan, Safi U., Ghimire, Subash, Talluri, Swapna, Rahman, Hammad, Khan, Muhammad U., Nasir, Fahad, Kaluski, Edo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828271/ https://www.ncbi.nlm.nih.gov/pubmed/29721108 http://dx.doi.org/10.1002/joa3.12017 |
Ejemplares similares
-
Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up
por: Gandhi, Kaushang, et al.
Publicado: (2010) -
Overweight and obesity as protective factors against mortality in nonischemic cardiomyopathy patients with an implantable cardioverter defibrillator
por: Zhou, Bin, et al.
Publicado: (2020) -
The impact of implantable cardioverter defibrillator on the prognosis of nonischemic dilated cardiomyopathy patients compared with standard medical treatments
por: Salehi Omran, Hossein, et al.
Publicado: (2023) -
Response: Impact of implantable cardioverter defibrillator on survival in patients with nonischemic dilated cardiomyopathy
por: Salehi Omran, Hossein, et al.
Publicado: (2023) -
Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)